Developing drug molecules for therapy with carbon monoxide

Chemical Society Reviews
Carlos C RomãoGonçalo J L Bernardes

Abstract

The use of Carbon Monoxide (CO) as a therapeutic agent has already been tested in human clinical trials. Pre-clinically, CO gas administration proved beneficial in animal models of various human diseases. However, the use of gaseous CO faces serious obstacles not the least being its well-known toxicity. To fully realise the promise of CO as a therapeutic agent, it is key to find novel avenues for CO delivery to diseased tissues in need of treatment, without concomitant formation of elevated, toxic blood levels of carboxyhemoglobin (COHb). CO-releasing molecules (CO-RMs) have the potential to constitute safe treatments if CO release in vivo can be controlled in a spatial and temporal manner. It has already been demonstrated in animals that CO-RMs can release CO and mimic the therapeutic effects of gaseous CO. While demonstrating the principle of treatment with CO-RMs, these first generation compounds are not suitable for human use. This tutorial review summarises the biological and chemical behaviour of CO, the current status of CO-RM development, and derives principles for the creation of the next generation of CO-RMs for clinical applications in humans.

References

Oct 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·R TenhunenR Schmid
Jan 15, 1993·Science·A VermaS H Snyder
Feb 9, 2002·Circulation Research·Roberto MotterliniColin J Green
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Masashi KitazawaAnumantha G Kanthasamy
Sep 27, 2002·Toxicology·Stanley T Omaye
May 10, 2003·Science·Katherine H Thompson, Chris Orvig
Jul 5, 2003·Circulation Research·James E ClarkRoberto Motterlini
Aug 19, 2003·Angewandte Chemie·Tony R JohnsonRoberto Motterlini
Dec 6, 2003·The Journal of Experimental Medicine·Brian S ZuckerbraunLeo E Otterbein
Jan 14, 2004·Kidney International·Begoña ArreguiFrancisco J Fenoy
Feb 28, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Stefan W Ryter, Leo E Otterbein
Sep 9, 2004·Microbiology and Molecular Biology Reviews : MMBR·Gary P RobertsRobert L Kerby
Nov 24, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Roberto MotterliniColin J Green
Sep 27, 2005·Drug Discovery Today·George J Brewer
Nov 1, 2005·Expert Opinion on Investigational Drugs·Roberto MotterliniRoberta Foresti
Dec 21, 2005·The Journal of Experimental Medicine·Refaat A F HegaziScott E Plevy
May 27, 2006·Chemical Society Reviews·Tim StorrChris Orvig
Aug 16, 2006·The Journal of Experimental Medicine·Brian S ZuckerbraunLeo E Otterbein
Sep 7, 2006·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·P F MannaioniE Masini
Sep 23, 2006·Journal of Cellular and Molecular Medicine·Atsunori NakaoNoriko Murase
Dec 22, 2006·The Journal of Nutrition·Janet A Novotny, Judith R Turnlund
Aug 19, 2007·Dalton Transactions : an International Journal of Inorganic Chemistry·Ian J S FairlambRoberto Motterlini
Nov 10, 2007·Dalton Transactions : an International Journal of Inorganic Chemistry·David ScapensRoberto Motterlini
Oct 1, 1949·Nature·T SJOSTRAND
Jun 14, 2008·Free Radical Biology & Medicine·Claude A Piantadosi
Jan 27, 2009·Chemical Society Reviews·Christian G Hartinger, Paul J Dyson
Apr 2, 2009·Environmental Health Perspectives·Neal C Burton, Tomás R Guilarte
May 7, 2009·Dalton Transactions : an International Journal of Inorganic Chemistry·Anthony J AtkinIan J S Fairlamb
Jun 30, 2009·Respiratory Care·Leo E Otterbein
Aug 8, 2009·Dalton Transactions : an International Journal of Inorganic Chemistry·Wei-Qiang ZhangJason M Lynam
Dec 31, 2009·Inorganic Chemistry·R Dale RimmerPeter C Ford
Feb 27, 2010·European Journal of Pharmacology·Nuria MaicasMaria José Alcaraz
Mar 30, 2010·Angewandte Chemie·Konrad MeisterMartina Havenith
Aug 10, 2010·Inorganic Chemistry·Fabio ZobiAnna Yu Bogdanova
Aug 18, 2010·Dalton Transactions : an International Journal of Inorganic Chemistry·Lindsay HewisonRoberto Motterlini
Aug 19, 2010·Chemical Communications : Chem Comm·Daniel CrespyAlexander Schiller
Aug 25, 2010·Organic & Biomolecular Chemistry·Tamil Selvi PitchumonyRoger Alberto
Sep 3, 2010·Nature Reviews. Drug Discovery·Roberto Motterlini, Leo E Otterbein
Nov 26, 2010·Science Translational Medicine·Csaba Szabo
Dec 7, 2010·Journal of the American Chemical Society·Urara HasegawaJeffrey A Hubbell
Dec 8, 2010·Journal of Inorganic Biochemistry·Robert KretschmerMatthias Westerhausen
Jan 6, 2011·Journal of the American Chemical Society·Teresa Santos-SilvaMaria J Romão

❮ Previous
Next ❯

Citations

Oct 20, 2012·Journal of the American Chemical Society·Agustin E PierriPeter C Ford
Apr 26, 2014·Dalton Transactions : an International Journal of Inorganic Chemistry·Sandesh PaiUlrich Schatzschneider
Jan 1, 2013·Oxidative Medicine and Cellular Longevity·Melissa KnauertPatty J Lee
Jan 31, 2013·Future Medicinal Chemistry·Fabio Zobi
Feb 13, 2016·Journal of Pharmaceutical Sciences·Xingyue JiBinghe Wang
Jan 17, 2016·The Journal of Pharmacy and Pharmacology·Bart PauwelsJohan Van de Voorde
Aug 5, 2015·Biomacromolecules·Eugénia NogueiraArtur Cavaco-Paulo
Mar 21, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Ana LoureiroArtur Cavaco-Paulo
Apr 25, 2014·British Journal of Pharmacology·Cláudia S F QueirogaHelena L A Vieira
Mar 19, 2014·British Journal of Pharmacology·U Schatzschneider
Apr 9, 2016·Journal of the American Chemical Society·Hiroaki KitagishiKoji Kano
Feb 25, 2015·Frontiers in Physiology·Ana S AlmeidaHelena L A Vieira
Jul 11, 2012·FEMS Microbiology Letters·Ana Filipa N TavaresLígia M Saraiva
Sep 18, 2015·The Journal of Physiology·Sara R OliveiraHelena L A Vieira
Sep 1, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Christoph SteigerLorenz Meinel
Sep 17, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Omer Salman QureshiJin-Ki Kim
Nov 12, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Christoph SteigerLorenz Meinel
Feb 11, 2015·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Prinessa Chellan, Peter J Sadler
Mar 28, 2017·Journal of the American Chemical Society·Upendar Reddy GAlexander Schiller
May 26, 2017·The Journal of Physical Chemistry. a·Tumpa SadhukhanSourav Pal
Jul 30, 2014·Angewandte Chemie·Sandra García-Gallego, Gonçalo J L Bernardes
Jan 23, 2017·The Journal of Chemical Physics·Ernest Awoonor-Williams, Christopher N Rowley
Apr 6, 2017·Acta Crystallographica. Section C, Structural Chemistry·Jenny Stenger-SmithPradip Mascharak
Feb 17, 2017·Dalton Transactions : an International Journal of Inorganic Chemistry·Gabriella TamasiRenzo Cini
Aug 8, 2015·Biomaterials Science·Hiroshi InabaTakafumi Ueno
Dec 18, 2015·Dalton Transactions : an International Journal of Inorganic Chemistry·Lígia S NobreLígia M Saraiva
Dec 19, 2015·Dalton Transactions : an International Journal of Inorganic Chemistry·Giuseppe SantoroFabio Zobi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.